Ocular Therapeutix, Inc.Announces Topline Results of Second Phase 3 Clinical Trial of DEXTENZA™ for the Treatment of Allergic Conjunctivitis

Monday, June 06, 2016 8:30 AM EDT

Webcast Presentation

Title
Ocular Therapeutix, Inc.Announces Topline Results of Second Phase 3 Clinical Trial of DEXTENZA™ for the Treatment of Allergic Conjunctivitis
Date / Time
Monday, June 06, 2016 8:30 AM EDT

Live Teleconference Information

Primary # -
Secondary # -

Replay Teleconference Information

Start Date -
Jun 6, 2016 at 10:30 AM EDT
Primary # -
Secondary # -
Passcode -
27710660